News In groundbreaking research, Tel Aviv U team records plants ‘talking’ for first time | The Times of Israel It has been known for some time that plants communicate with one another, but Israeli…Super UserApril 3, 2023
News The AI genie is out of the bottle: Should it be crammed back inside? By Tom Still MADISON, Wis. -- Society has been here many times before. A little…Super UserApril 3, 2023
News TEDCO’s Maryland Innovation Initiative Announced Recent Investments $600,000 invested into 3 new ventures and $1.6Million awarded to 12 project grants COLUMBIA, Md.…Super UserMarch 30, 2023
News From Serbia and China to College Park – Maryland Today When husband and wife Zairen Sun Ph.D. ’98 and Beibei Li Ph.D. ’98 arrived in…Super UserMarch 30, 2023
News U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment NARCAN® Naloxone HCl Nasal Spray 4 mg is currently the first and only prescription strength naloxone…Super UserMarch 30, 2023
News Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates MARCH 28, 2023 - GAITHERSBURG, Md., (BUSINESS WIRE) -- Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage…Super UserMarch 30, 2023
News MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology Leiden, the Netherlands , March 28, 2023 / B3C newswire / -- MIMETAS, a global leader…Super UserMarch 30, 2023
BHI Weekly News Archives 551st Edition, March 28, 2023 Trouble Viewing This Email: Click Here March 28, 2023 FOUNDING MEMBER OF Exploring…Super UserMarch 28, 2023
News Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences Ready to explore the frontiers of cancer therapeutics? Discover how AUM Biosciences, with a key…Super UserMarch 27, 2023
News MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr) ROCKVILLE, MD, March 22, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on…Super UserMarch 27, 2023